Jacobi Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Buy |
8,167
+308
| +4% | +$47.2K | 0.07% | 260 |
|
|
2025
Q4 | $1.08M | Sell |
7,859
-24
| -0.3% | -$3.14K | 0.06% | 268 |
|
|
2025
Q3 | $1.01M | Buy |
7,883
+390
| +5% | +$47.6K | 0.06% | 275 |
|
|
2025
Q2 | $907K | Buy |
7,493
+404
| +6% | +$45.5K | 0.06% | 279 |
|
|
2025
Q1 | $790K | Buy |
7,089
+310
| +5% | +$33K | 0.06% | 284 |
|
|
2024
Q4 | $660K | Sell |
6,779
-156
| -2% | -$16.6K | 0.05% | 303 |
|
|
2024
Q3 | $798K | Buy |
6,935
+443
| +7% | +$50.3K | 0.06% | 285 |
|
|
2024
Q2 | $691K | Buy |
6,492
+101
| +2% | +$10.1K | 0.06% | 274 |
|
|
2024
Q1 | $618K | Sell |
6,391
-535
| -8% | -$54.9K | 0.06% | 273 |
|
|
2023
Q4 | $699K | Buy |
6,926
+105
| +2% | +$10.1K | 0.07% | 241 |
|
|
2023
Q3 | $695K | Hold |
6,821
| – | – | 0.08% | 227 |
|
|
2023
Q2 | $688K | Buy |
6,821
+27
| +0.4% | +$2.7K | 0.08% | 230 |
|
|
2023
Q1 | $625K | Sell |
6,794
-778
| -10% | -$67.9K | 0.07% | 234 |
|
|
2022
Q4 | $687K | Buy |
7,572
+129
| +2% | +$10.9K | 0.09% | 217 |
|
|
2022
Q3 | $566K | Buy |
7,443
+383
| +5% | +$31.7K | 0.08% | 231 |
|
|
2022
Q2 | $597K | Buy |
7,060
+1,631
| +30% | +$143K | 0.08% | 224 |
|
|
2022
Q1 | $476K | Buy |
5,429
+359
| +7% | +$31.1K | 0.06% | 272 |
|
|
2021
Q4 | $443K | Buy |
5,070
+166
| +3% | +$13.8K | 0.05% | 293 |
|
|
2021
Q3 | $401K | Buy |
4,904
+237
| +5% | +$21.3K | 0.05% | 289 |
|
|
2021
Q2 | $426K | Buy |
4,667
+30
| +0.6% | +$2.67K | 0.06% | 264 |
|
|
2021
Q1 | $396K | Sell |
4,637
-88
| -2% | -$7.9K | 0.06% | 252 |
|
|
2020
Q4 | $446K | Buy |
4,725
+231
| +5% | +$20.2K | 0.07% | 222 |
|
|
2020
Q3 | $391K | Buy |
4,494
+107
| +2% | +$9.27K | 0.07% | 219 |
|
|
2020
Q2 | $383K | Sell |
4,387
-203
| -4% | -$17.5K | 0.07% | 210 |
|
|
2020
Q1 | $378K | Buy |
4,590
+813
| +22% | +$72.5K | 0.08% | 185 |
|
|
2019
Q4 | $358K | Hold |
3,777
| – | – | 0.07% | 225 |
|
|
2019
Q3 | $328K | Buy |
3,777
+102
| +3% | +$9.16K | 0.06% | 229 |
|
|
2019
Q2 | $336K | Sell |
3,675
-55
| -1% | -$4.66K | 0.07% | 222 |
|
|
2019
Q1 | $321K | Buy |
3,730
+213
| +6% | +$17.1K | 0.08% | 174 |
|
|
2018
Q4 | $270K | Buy |
3,517
+805
| +30% | +$62.7K | 0.07% | 185 |
|
|
2018
Q3 | $209K | Buy |
2,712
+406
| +18% | +$30K | 0.06% | 213 |
|
|
2018
Q2 | $156K | Buy |
2,306
+47
| +2% | +$3.24K | 0.05% | 246 |
|
|
2018
Q1 | $161K | Buy |
2,259
+579
| +34% | +$44.1K | 0.05% | 221 |
|
|
2017
Q4 | $130K | Hold |
1,680
| – | – | 0.04% | 223 |
|
|
2017
Q3 | $129K | Sell |
1,680
-829
| -33% | -$62.6K | 0.04% | 205 |
|
|
2017
Q2 | $185K | Sell |
2,509
-1,045
| -29% | -$74.1K | 0.07% | 130 |
|
|
2017
Q1 | $235K | Buy |
3,554
+287
| +9% | +$19.1K | 0.12% | 85 |
|
|
2016
Q4 | $213K | Buy |
3,267
+88
| +3% | +$5.71K | 0.13% | 78 |
|
|
2016
Q3 | $225K | Hold |
3,179
| – | – | 0.11% | 80 |
|
|
2016
Q2 | $234K | Buy |
+3,179
| New | +$220K | 0.12% | 76 |
|
Other funds holding NVS
Jacobi Capital Management's NVS Position: Q1 2026 in Review
Jacobi Capital Management increased its Novartis (NVS) stake by 3.9% in Q1 2026, buying an estimated $47.2K and bringing the position to 8,167 shares worth $1.25M. The position accounts for 0.07% of the portfolio, ranked #260.
Jacobi Capital Management first reported a position in NVS in Q2 2016 and has held it in 40 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Jacobi Capital Management held 8,167 shares of Novartis worth $1.25M as of Q1 2026.
- Jacobi Capital Management bought 308 Novartis shares in Q1 2026, an estimated $47.2K.
- Novartis made up 0.07% of Jacobi Capital Management's portfolio in Q1 2026, its #260 holding.
- Jacobi Capital Management first reported a position in Novartis in Q2 2016 and has held it in 40 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.